PT  - JOURNAL ARTICLE
AU  - Marthe E. Ribbink
AU  - Emma Stornebrink
AU  - Remco Franssen
AU  - Annemarieke de Jonghe
AU  - Janet L. MacNeil Vroomen
AU  - Bianca M. Buurman
AU  - on behalf of the AGCH-study group
TI  - Incidence of delirium in an acute geriatric community hospital: an exploratory analysis of an observational cohort study controlled with a meta-analysis of incidences from literature
AID  - 10.1101/2021.05.31.21257974
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.31.21257974
4099  - http://medrxiv.org/content/early/2021/06/01/2021.05.31.21257974.short
4100  - http://medrxiv.org/content/early/2021/06/01/2021.05.31.21257974.full
AB  - Background Delirium in hospitalised older adults is associated with negative health outcomes. Admission to an alternative care setting may lower the incidence of delirium. The Acute Geriatric Community Hospital (AGCH) was recently opened in the Netherlands and uses a multi-component non-pharmacological intervention strategy to prevent delirium.Objective To describe the incidence of delirium found in the AGCH and compare this incidence to a hospital control group found in literature.Design Prospective cohort study; exploratory meta-analysis of proportions.Setting The AGCH is an acute geriatric unit in an intermediate care facility.Participants Patients aged >65 years with acute medical conditions admitted to the AGCH.Methods Delirium assessment using the Confusion Assessment Method (CAM) upon admission and on day one, two and three or until delirium had resolved. Patients’ charts were reviewed if CAM was missing. In an logistic mixed-effects model, the delirium incidence rate in AGCH was compared to pooled delirium incidence rates from six studies found in a high-quality review.Results 214 patients from the AGCH (mean age 81.9 years, 47% male, 12% with a history of dementia) were included in the analysis. Delirium developed in 8% (18/214) (95% CI [confidence interval] 5-13%) of patients during AGCH admission compared to 16% (95% CI 12-21%) in hospitals. Admission to the AGCH was associated with a decreased delirium incidence rate compared to the hospital control group (OR [odds ratio]= 0.49, 95% CI 0.24-0.98, p-value=.044).Conclusions The delirium incidence in the AGCH was relatively low compared to those incidences found in general hospitals.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNL7896Clinical Protocols https://bmjopen.bmj.com/content/bmjopen/10/3/e033802.full.pdf Funding StatementThis work was supported by ZonMw, the Netherlands Organization for Health Research and Development [grant number 808393598041] and the PVE- fund. These funders played no role in the design or execution of this research. Moreover, the care provided at the AGCH is provided in a partnership between Cordaan, a community and home-care organization and the Amsterdam University Medical Centre, location Academic Medical Centre. The AGCH is financially supported by Zilveren Kruis, a health insurance company. Zilveren Kruis played a role in the initiation and design, but no role in the execution, analysis and writing of this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Amsterdam University Medical Centers, location AMC waived the obligation for the study to undergo formal ethical approval as described under Dutch law.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is currently not available for reuse